Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: A French Sarcoma Group (FSG)/ US National Cancer Institute phase II collaborative study.
暂无分享，去创建一个
J. Blay | S. Mathoulin-Pélissier | M. Toulmonde | A. Italiano | A. Le Cesne | I. Ray-Coquard | S. Piperno-Neumann | C. Bellera | N. Penel | E. Bompas | F. Duffaud | C. Chevreau | N. Entz-Werlé | M. Pulido